Paper Details

  1. Home
  2. Paper Details

Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: a prospective non-controlled case series.

Author: KelekciHandan Kiymet, KelekciSefa, OzdemirOrcun, SutNecdet, UncuHikmet Gulsen, YilmazBulent

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Topical pimecrolimus 1% cream was effective and safe in treating pruritus vulvae in postmenopausal women with vulvar lichen simplex chronicus.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Pruritus vulvae may have a variety of causes, such as infections, dermatologic disorders or non-neoplastic/neoplastic vulvar diseases. OBJECTIVES: To investigate the efficacy and side effects of topical pimecrolimus 1% cream for pruritus vulvae. METHODS: Twelve postmenopausal diabetic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/09546630801955341

データ提供：米国国立医学図書館（NLM）

Pimecrolimus 1% Cream for Pruritus in Postmenopausal Diabetic Women

This study explores the efficacy and safety of topical pimecrolimus 1% cream in treating pruritus vulvae, a condition characterized by itching in the vulvar area. The researchers conducted a prospective non-controlled case series involving postmenopausal diabetic women with vulvar lichen simplex chronicus and found that pimecrolimus 1% cream was effective in reducing pruritus. This finding suggests that pimecrolimus 1% cream could be a valuable treatment option for pruritus vulvae in this patient population.

Pimecrolimus 1% Cream - A Potential Solution for Pruritus Vulvae

The study's findings indicate that pimecrolimus 1% cream could be an effective treatment option for pruritus vulvae in postmenopausal diabetic women with vulvar lichen simplex chronicus. The researchers found that the cream significantly reduced pruritus in the study participants, highlighting its potential as a valuable treatment modality for this condition.

Seeking Relief from Itching

Imagine a camel traversing a sandy desert, experiencing the discomfort of itchy skin due to exposure to harsh elements. Just as the camel seeks relief from irritation, individuals with pruritus vulvae need effective treatments to manage their symptoms. This study suggests that pimecrolimus 1% cream could be a promising solution for this condition, offering relief from itching and improved quality of life.

Dr.Camel's Conclusion

This study provides evidence for the efficacy and safety of topical pimecrolimus 1% cream in treating pruritus vulvae in postmenopausal diabetic women with vulvar lichen simplex chronicus. The researchers found that the cream significantly reduced pruritus in the study participants, suggesting that it could be a valuable treatment option for this condition. Further research is needed to confirm these findings and to evaluate the long-term effects of pimecrolimus 1% cream in treating pruritus vulvae.
Date :
  1. Date Completed 2009-03-03
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

19160532

DOI: Digital Object Identifier

10.1080/09546630801955341

Related Literature

Article Analysis
・Side Effects of pimecrolimus topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.